Literature DB >> 24792773

Modulation of miR-203 and its regulators as a function of time during the development of 7, 12 dimethylbenz [a] anthracene induced mouse skin tumors in presence or absence of the antitumor agents.

Prakash Tiwari1, Krishna P Gupta2.   

Abstract

We investigated the chemopreventive effects of naturally occurring compounds like butyric acid (BA), nicotinamide (NA) and calcium glucarate (CAG) individually or in combination in 7, 12-dimethylbenz [a] anthracene (DMBA) treated mouse skin at 4 and 16 weeks, the time before and after the tumor development. DMBA application did not show any skin tumors at 4 weeks but well defined tumors appeared at 16 weeks. BA, NA or CAG prevented the tumor development significantly but the protection was highly enhanced when all these compounds were given together. In order to see the molecular changes progressing with tumors, we showed the downregulation of tumor suppressor miR-203 at 16 weeks and upregulation of histone deacetylases (HDAC), DNA methyltransferase, promoter methylation of miR-203 at 4 or 16 weeks. Regulators of micro RNA biogenesis such as DICER1 and Ago2 were also deregulated by DMBA. Proto-oncogene c-myc and BMI1 were upregulated and tumor suppressor gene p16 was downregulated by DMBA as a function of time. Effects of BA, NA or CAG were more pronounced after 16 weeks as compared to 4 weeks in preventing the tumor development and altered gene expression. Concomitant administration of BA, NA and CAG tried to prevent these alterations more effectively than that of individual compound possibly by regulating miR-203 status through epigenetic or biogenetic modulations before and after the tumor development. Study provides a rationale for chemoprevention by combination of different compounds targeting miR-203.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemoprevention; DICER1; DMBA; Epigenetics; Skin tumor; miR-203

Mesh:

Substances:

Year:  2014        PMID: 24792773     DOI: 10.1016/j.taap.2014.04.020

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

Review 1.  Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates.

Authors:  Nasreddine El Omari; Saad Bakrim; Mohamed Bakha; José M Lorenzo; Maksim Rebezov; Mohammad Ali Shariati; Sara Aboulaghras; Abdelaali Balahbib; Mars Khayrullin; Abdelhakim Bouyahya
Journal:  Nutrients       Date:  2021-10-22       Impact factor: 5.717

Review 2.  Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates.

Authors:  Abdelhakim Bouyahya; Naoufal El Hachlafi; Tarik Aanniz; Ilhame Bourais; Hamza Mechchate; Taoufiq Benali; Mohammad Ali Shariati; Pavel Burkov; José M Lorenzo; Polrat Wilairatana; Mohammad S Mubarak; Nasreddine El Omari
Journal:  Molecules       Date:  2022-04-15       Impact factor: 4.927

Review 3.  Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Subhasree Nag; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2015-07-30       Impact factor: 12.944

Review 4.  Diet phytochemicals and cutaneous carcinoma chemoprevention: A review.

Authors:  Siliang Wang; Peiliang Shen; Jinrong Zhou; Yin Lu
Journal:  Pharmacol Res       Date:  2017-02-24       Impact factor: 10.334

Review 5.  Polycomb Repressor Complex 2 in Genomic Instability and Cancer.

Authors:  Zoe Veneti; Kalliopi K Gkouskou; Aristides G Eliopoulos
Journal:  Int J Mol Sci       Date:  2017-07-30       Impact factor: 5.923

Review 6.  Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer.

Authors:  Xinqiang Wu; Yuanbing Wu; Liangmei He; Longhuo Wu; Xiangcai Wang; Zhiping Liu
Journal:  J Cancer       Date:  2018-06-15       Impact factor: 4.207

7.  MicroRNA-203 mimics age-related aortic smooth muscle dysfunction of cytoskeletal pathways.

Authors:  Christopher J Nicholson; Francesca Seta; Sophie Lee; Kathleen G Morgan
Journal:  J Cell Mol Med       Date:  2016-08-09       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.